Fig. 3From: Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trialsGender distribution in OCEAN study and in selected RCTs, by indication. Legend: Proportion of female patients (red) and male patients (blue) at baseline. aHatched columns: Gender group not explicitly provided in source data; data for respective other gender used for calculation of percentage (may include missing/unavailable data). bData provided for number of eyes, not number of patients. Abbreviations: BRVO: branch retinal vein occlusion; CRVO: central retinal vein occlusion; DME: diabetic macular oedema; N: number of patients; nAMD: neovascular age-related macular degeneration; RCT: randomized controlled trialBack to article page